(Q44659829)

5 December 2017

1 reference

title

The metabolic syndrome and type 2 diabetes: role of the adipocyte (English)

1 reference

5 December 2017

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Cardiology and cardiovascular medicine

3 April 2024

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

3 April 2024

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

3 April 2024

author name string

Ruth McPherson

1

1 reference

5 December 2017

Peter H. Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624130

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14624130

3 April 2024

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://journals.lww.com/00041433-200312000-00001

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Current Opinion in Lipidology

3 April 2024

published in

1 reference

5 December 2017

volume

14

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

549-553

1 reference

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

3 April 2024

2

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Weight as a risk factor for clinical diabetes in women

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Obesity and insulin resistance

3 April 2024

5

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Mechanism of free fatty acid-induced insulin resistance in humans

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Cellular mechanisms of insulin resistance

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Regional adiposity and morbidity

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

3 April 2024

You are what you secrete

13

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Insulin signalling and the regulation of glucose and lipid metabolism

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Mechanisms of TNF-alpha-induced insulin resistance

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

TNF-alpha and insulin resistance: summary and future prospects

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

3 April 2024

22

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients

3 April 2024

23

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Tumour necrosis factor-alpha (TNF-alpha) polymorphisms-857C/A and -863C/A are associated with TNF-alpha secretion from human adipose tissue

3 April 2024

26

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The irresistible biology of resistin

3 April 2024

27

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

3 April 2024

28

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Mechanisms regulating adipocyte expression of resistin

3 April 2024

30

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

3 April 2024

31

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

3 April 2024

32

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

3 April 2024

33

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

3 April 2024

34

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

3 April 2024

35

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

3 April 2024

36

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

3 April 2024

37

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

3 April 2024

38

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

3 April 2024

39

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Linkage exclusion analysis of the chromosome 11 region containing UCP2 and UCP3 with obesity-related phenotypes in Mexican Americans

3 April 2024

40

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome

3 April 2024

41

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Obesity in the new millennium

3 April 2024

42

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Weight-reducing effects of the plasma protein encoded by the obese gene

3 April 2024

43

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

3 April 2024

44

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

3 April 2024

45

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Disruption of adiponectin causes insulin resistance and neointimal formation

3 April 2024

46

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Signaling pathways in insulin action: molecular targets of insulin resistance

3 April 2024

47

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

CAP defines a second signalling pathway required for insulin-stimulated glucose transport

3 April 2024

48

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Turning down insulin signaling.

3 April 2024

49

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

3 April 2024

50

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Signaling pathways mediating insulin-stimulated glucose transport

3 April 2024

51

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

TCGAP, a multidomain Rho GTPase-activating protein involved in insulin-stimulated glucose transport

3 April 2024

52

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin

3 April 2024

53

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Conventional kinesin KIF5B mediates insulin-stimulated GLUT4 movements on microtubules

3 April 2024

54

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Dose-response curves for in vivo insulin sensitivity in individual tissues in rats

3 April 2024

55

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

3 April 2024

57

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Global functional profiling of gene expression.

3 April 2024

58

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis

3 April 2024

59

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus

3 April 2024

60

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from subjects with Type II diabetes mellitus

3 April 2024

61

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases

3 April 2024

62

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

3 April 2024

63

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

3 April 2024

65

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

3 April 2024

66

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Adipogenesis and obesity: rounding out the big picture

3 April 2024

67

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Transcriptional activation of adipogenesis

3 April 2024

69

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Role of Foxa-2 in adipocyte metabolism and differentiation

3 April 2024

70

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice

3 April 2024

71

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.

3 April 2024

72

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats

3 April 2024

73

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans

3 April 2024

74

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance

3 April 2024

75

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

FOXC2 mRNA Expression and a 5' untranslated region polymorphism of the gene are associated with insulin resistance.

3 April 2024

76

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians

3 April 2024

77

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Systematic search for single nucleotide polymorphisms in the FOXC2 gene: the absence of evidence for the association of three frequent single nucleotide polymorphisms and four common haplotypes with Japanese type 2 diabetes

3 April 2024

78

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Importance of identifying the overweight patient who will benefit the most by losing weight

3 April 2024

79

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

3 April 2024

Metformin: An Update

80

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

3 April 2024

81

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials

3 April 2024

82

1 reference

https://api.crossref.org/works/10.1097/00041433-200312000-00001

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference